When was Nuclein founded?

Nuclein was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Nuclein located?

Nuclein is headquartered in Austin, United States.

How many employees does Nuclein have?

As of Mar 31, 2026, the latest employee count at Nuclein is 66.

Is Nuclein a funded company?

Nuclein is a funded company, having raised a total of $20M across 5 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Mar 24, 2021.

When was the latest funding round of Nuclein?

Nuclein's latest funding was a $***** Conventional Debt round on Jul 01, 2025, with participation from 0 investor.

Where does Nuclein rank among its competitors?

Nuclein ranks 1st amongst 6 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors.

Who are the top competitors of Nuclein?

Nuclein's top competitors include CellScope, Mel-Mont Medical and Orphidia. Among them, Nuclein secured the most recent funding round in July, 2025.

Nuclein - 2026 Company Profile, Team, Funding & Competitors

Nuclein is a series B company based in Austin (United States), founded in 2017 by Alan Blake and Richard Crockett. It operates as a Developer of handheld PCR device for the detection of infectious disease. Nuclein has raised $20M in funding from Trinity Investors. The company has 6 active competitors, including 3 that are funded. Its top competitors include companies like CellScope, Mel-Mont Medical and Orphidia.

Company Details

Developer of handheld PCR device for the detection of infectious disease. The device NUCLEIN uses standard real-time PCR, requires no technical expertise, battery-powered, results in one hour. This device can be used for covid diagnosis.

Website: nuclein.com
Social

Key Metrics

Founded Year

2017

Location

Austin, United States

Stage

Series B

Total Funding

$20M in 5 rounds

Latest Funding Round

Conventional Debt, Jul 01, 2025, $*****

Investors

Trinity Investors

Ranked

1^st among 6 active competitors

Employee Count

66 as on Mar 31, 2026

Similar Companies

CellScope & 11 more

View Nuclein's full profile

Nuclein has raised a total funding of $20M over 5 rounds. Its first funding round was on Mar 24, 2021. Nuclein has 1 institutional investor.

Here is the list of recent funding rounds of Nuclein:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2025	2073363	Conventional Debt	5975788	5903224	4440939	5111768
Jan 23, 2025	8203325	Series B	7009504	1099406	3985313	9627983
Dec 15, 2023	9675059	Conventional Debt	2087617	9541252	2350481	4750313

Access funding benchmarks and valuations. Sign up today!

View details of Nuclein's funding rounds and investors

The founders of Nuclein are Alan Blake and Richard Crockett.

Here are the details of Nuclein's key team members:

Alan Blake: Co-Founder of Nuclein and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Richard Crockett: Co-Founder of Nuclein and founder of 1 other company.

View details of Nuclein's Founder profiles and Board Members

Nuclein's employee count trend

Nuclein has 66 employees as of Mar 26. Here is Nuclein's employee count trend over the years:

Uncover Nuclein's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nuclein include CellScope, Mel-Mont Medical and Orphidia. Here is the list of Top 10 competitors of Nuclein, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nuclein 2017, Austin (United States), Series B	Developer of handheld PCR device for the detection of infectious disease	$20M	Trinity Investors	41/100
2nd	CellScope 2010, San Francisco (United States), Series A	In-ear visibility using mobile device for at-home diagnosis	$4.62M	Khosla Ventures, Montage Ventures & 1 others	37/100
3rd	Mel-Mont Medical 2014, Doral (United States), Seed	Developer of molecular screening devices for the early detection of infectious diseases	$3M	-	28/100
4th	Orphidia 2013, San Francisco (United States), Funding Raised	DIY device for point-of-care diagnostics	-	Abenteuer, Hemisphere Ventures & 5 others	22/100
5th	ParaSonic 2014, Ramat Gan (Israel), Deadpooled	Home-use device for the elimination of lice & other parasites	$1.6M	NGT HealthCare II, 3D Innotech	18/100
6th	Guangzhou Berrcom Medical Device 2000, Guangzhou (China), Unfunded	Developer of Bluetooth based device for monitoring fever	-	-	18/100
7th	PreDiagnose 2017, Karlslunde (Denmark), Funding Raised	Developer of point of care devices to detect early and intermittent bacterial infections	-	Nordic Innovators	15/100
8th	Hoope 2014, Lima (Peru), Deadpooled	Wearable lab-on-a-chip device for STD diagnosis	-	StartUp Peru	14/100
9th	Xtest 2015, Tempe (United States), Deadpooled	Biosensors and App to diagnose sexually transmitted diseases	$250K	-	13/100
10th	Safe Shower 2018, Tel Aviv Yafo (Israel), Deadpooled	Developer of patented shower head for preventing legionnaires' disease	-	-	9/100